Illumina’s rejection of Roche’s offer

Illumina Inc., a company specialized in developing life sciences tools and systems for genetic analysis, has rejected the Roche’s offer

Read more

Roche has expanded the tender offer for Illumina

Roche, a Switzerland based company specialized in pharmaceuticals and diagnostics, has announced that the tender offer for Illumina has been

Read more

Zelboraf, skin cancer medicine, has gotten approval from European Drug Regulators

Roche has announced, on Monday, that the European Drug Regulators have approved the company’s new skin cancer medicine, i.e. Zelboraf

Read more

Avastin did not fulfill expectations about ovarian cancer treatment

Avastin, an anticancer drug by Genentech which got approval in Europe last week for advanced ovarian cancer, has lost expectations

Read more

Two new auspicious therapeutic strategies against Breast Cancer

Two companies have raised a strong hope for the treatment of breast cancer. These companies are Roche and Novartis. Breast

Read more
%d bloggers like this: